148 related articles for article (PubMed ID: 9973257)
1. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization.
Zhou XF; Shen XQ; Shemshedini L
Mol Endocrinol; 1999 Feb; 13(2):276-85. PubMed ID: 9973257
[TBL] [Abstract][Full Text] [Related]
2. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun.
Schroen DJ; Brinckerhoff CE
J Cell Physiol; 1996 Nov; 169(2):320-32. PubMed ID: 8908199
[TBL] [Abstract][Full Text] [Related]
5. Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription.
Shen XQ; Bubulya A; Zhou XF; Khazak V; Golemis EA; Shemshedini L
Endocrine; 1999 Jun; 10(3):281-9. PubMed ID: 10484292
[TBL] [Abstract][Full Text] [Related]
6. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
Lin F; Xiao D; Kolluri SK; Zhang X
Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
[TBL] [Abstract][Full Text] [Related]
7. Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid.
Konta T; Xu Q; Furusu A; Nakayama K; Kitamura M
J Biol Chem; 2001 Apr; 276(16):12697-701. PubMed ID: 11278809
[TBL] [Abstract][Full Text] [Related]
8. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
9. Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor.
Lin F; Kolluri SK; Chen GQ; Zhang XK
J Biol Chem; 2002 Jun; 277(24):21414-22. PubMed ID: 11934895
[TBL] [Abstract][Full Text] [Related]
10. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
11. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C.
Ivorra C; Kubicek M; González JM; Sanz-González SM; Alvarez-Barrientos A; O'Connor JE; Burke B; Andrés V
Genes Dev; 2006 Feb; 20(3):307-20. PubMed ID: 16452503
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.
Maroder M; Farina AR; Vacca A; Felli MP; Meco D; Screpanti I; Frati L; Gulino A
Mol Endocrinol; 1993 Apr; 7(4):570-84. PubMed ID: 8388998
[TBL] [Abstract][Full Text] [Related]
13. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors.
Takeshita A; Watanabe A; Takada Y; Hanazawa S
J Biol Chem; 2000 Oct; 275(41):32220-6. PubMed ID: 10915783
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative effects of nuclear receptors on transcription activation by AP-1 of the human choline acetyltransferase proximal promoter.
Schmitt M; Bausero P; Simoni P; Queuche D; Geoffroy V; Marschal C; Kempf J; Quirin-Stricker C
J Neurosci Res; 1995 Feb; 40(2):152-64. PubMed ID: 7745608
[TBL] [Abstract][Full Text] [Related]
15. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1.
Doucas V; Brockes JP; Yaniv M; de Thé H; Dejean A
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9345-9. PubMed ID: 8415704
[TBL] [Abstract][Full Text] [Related]
16. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
17. Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells.
Johnson TA; Li J; Beer DG
Mol Carcinog; 1996 Oct; 17(2):70-7. PubMed ID: 8890955
[TBL] [Abstract][Full Text] [Related]
18. Identification of the AP1-antagonism domain of retinoic acid receptors.
DiSepio D; Sutter M; Johnson AT; Chandraratna RA; Nagpal S
Mol Cell Biol Res Commun; 1999 Apr; 1(1):7-13. PubMed ID: 10329471
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins.
Harrison RJ; McNeil GP; Dobner PR
Mol Endocrinol; 1995 Aug; 9(8):981-93. PubMed ID: 7476995
[TBL] [Abstract][Full Text] [Related]
20. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
